GHK-Cu and vitamin C serve different roles
The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion
This "triple threat" approach is designed to tackle metabolic dysfunction from three distinct angles: appetite suppression, glucose regulation, and calorie burning
Another option is emerging
Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors
Some of them modulate your immune system